Narayana Hrudayalaya (NSE:NH) Risk Assessment

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:NH Narayana Hrudayalaya Ltd NSE:NH
94 GF Score
Price ₹1,961.50
GF Value ₹2,286.71
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Narayana Hrudayalaya Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Narayana Hrudayalaya is: Low Risk: Strong fundamentals, worth long-term holding.

Narayana Hrudayalaya  (NSE:NH) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Narayana Hrudayalaya Risk Assessment Related Terms

NSE:NH vs HCA, THC, DVA: Risk Assessment Comparison

For the Medical Care Facilities subindustry, Narayana Hrudayalaya's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Narayana Hrudayalaya Risk Assessment vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Narayana Hrudayalaya's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Narayana Hrudayalaya's Risk Assessment falls into.


NSE:NH
94GF Score
Narayana Hrudayalaya Ltd NSE:NH
Risk Assessment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Narayana Hrudayalaya (NSE:NH) Overvalued in 2026?

Based on GuruFocus' analysis, Narayana Hrudayalaya stock appears to be undervalued. The current stock price of ₹1,961.50 is trading 14.2% below its estimated GF Value™ of ₹2,286.71. GuruFocus considers Narayana Hrudayalaya to be Modestly Undervalued.

Key valuation signals for NSE:NH:

  • Risk Assessment:
  • GF Value™: ₹2,286.71 vs. price of ₹1,961.50 (14.2% below fair value)
  • GF Score™: 94/100 with 2 warning signs

No single metric tells the full story. See the NSE:NH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Narayana Hrudayalaya Business Description

Other Exchanges 539551:India
Address Hosur Road, Anekal Taluk, Number 261/A, 2nd Floor, Bommasandra Industrial Area, Bengaluru, KA, IND, 560099
Narayana Hrudayalaya Ltd is an India-based medical and healthcare service provider. The company is engaged in the business of running and operating hospitals, clinics, health centers, nursing homes, and other related activities. The Company's sole operating segment is Medical and Healthcare Related Services. It also provides surgery services such as Cardiac Surgery, nephrology, urology, neurology, neurosurgery, endocrinology, orthopaedics, internal medicine, obstetrics, gynaecology, paediatrics, neonatology, gastroenterology, and oncology. It has business operations in India and the Rest of the world, of which the maximum revenue is generated from the business operations in India.
94GF Score

Get the complete analysis for NSE:NH

Risk Assessment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,961.50
Price
₹2,286.71
GF Value